Greenwich LifeSciences Financials - Benzinga

SPY765.54−0.75%QQQ736.52−1.07%BTC/USD83,355.87−1.29%DIA514.15−0.65%GLD378.92−3.68%TLT78.55−0.98%

Greenwich LifeSciences Inc

GLSINASDAQ

Trade with Public

Trade with Public

$18.41

0.191.04%

Last update: Sep 28, 5:17 AM

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

Greenwich LifeSciences Financials

Greenwich LifeSciences (GLSI) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Greenwich LifeSciences Q4 EPS $(0.58) Misses $(0.31) Estimate

Greenwich LifeSciences (NASDAQ:GLSI) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimate of $(0.31) by 87.1 percent. This is a 4.92 percent increase over losses of $(0.61) per share

Benzinga Newsdesk

PRO
Greenwich LifeSciences Q1 EPS $(0.25) Down From $(0.19) YoY

Greenwich LifeSciences (NASDAQ:GLSI) reported quarterly losses of $(0.25) per share. This is a 31.58 percent decrease over losses of $(0.19) per share from the same period last year.

Benzinga Newsdesk

Crude Oil Prices Fall Sharply; Greenwich LifeSciences Shares Spike Higher

U.S. stocks traded mixed toward the end of trading after recording losses in the previous session.

Lisa Levin

U.S. Stocks Turn Higher; PepsiCo Posts Upbeat Q2 Results

U.S. stocks turned higher midway through trading after recording losses in the previous session.

Lisa Levin

Why Markets Are Trading Mixed; US Small Business Optimism Tumbles To This Level

U.S. stocks traded mixed this morning after recording losses in the previous session.

Lisa Levin

Mid-Morning Market Update: Markets Open Lower; Microsoft To Acquire Nuance

Following the market opening Monday, the Dow traded down 0.27% to 33,708.58 while the NASDAQ fell 0.54% to 13,825.03. The S&P also fell, dropping 0.20% to 4,120.48.

Lisa Levin

© 2026 Benzinga | All Rights Reserved